Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Analysis of Postural Control of COPD Patients (ATTRACTION) (ATTRACTION)

14 gennaio 2022 aggiornato da: Graziella Brinchault, University of Rennes 2

Quantified Analysis of Postural Control of COPD Patients During Tasks of Daily Living

Chronic Obstructive Pulmonary Disease (COPD) is a common chronic respiratory disease, causing disabling respiratory symptoms and impairing patients' quality of life. Currently one of the leading causes of death worldwide, COPD is a major socio-economic concern. It is also accompanied by extremely frequent extra-respiratory manifestations (or co-morbidities). Among these secondary manifestations, the equilibrium of these patients is subject to modifications: thus, numerous studies have shown that the equilibrium of COPD patients was altered compared to healthy age-matched subjects. This alteration is associated with a greater functional limitation and a higher risk of falling. Although this impairment has been demonstrated clinically, the balance of these patients has never been analysed using quantified movement analysis tools during tasks similar to those performed in daily life. Moreover, the underlying mechanisms remain unknown and the possible associations with several clinical factors of interest (pain, dyspnea, muscle function...) have not yet been assessed. The hypotheses of this project are that (1) the postural control of COPD patients is altered compared to healthy subjects during tasks of daily living and these changes can be characterised. (2) Several clinical factors are associated with these changes.

Panoramica dello studio

Tipo di studio

Osservativo

Iscrizione (Anticipato)

32

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Backup dei contatti dello studio

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Bambino
  • Adulto
  • Adulto più anziano

Accetta volontari sani

Sessi ammissibili allo studio

Tutto

Metodo di campionamento

Campione non probabilistico

Popolazione di studio

COPD patients that realize their medical follow-up at University Hospital of Rennes

Descrizione

Inclusion Criteria:

  • COPD patients GOLD stage 2 and 3 (A-D)
  • In accordance with Article L1121-8-1 of the Public Health Code, participants must be affiliated to a social security scheme or benefit from such a scheme.

Exclusion Criteria:

  1. the presence of long-term or exercise-based oxygen therapy,
  2. the presence of a medically diagnosed pathology causing manifest disorders of balance,
  3. the inability to walk 150 m without stopping and to climb or descend stairs,
  4. a history of pneumonectomy or lobectomy within the last six months,
  5. the existence of an acute respiratory exacerbation within the last two months,
  6. the presence of obvious cognitive impairment that impairs comprehension of instructions,
  7. body mass index less than 21 or more than 35 kg/m².
  8. Person referred to in articles L. 1121-5 to L. 1121-8 and L. 1121-12 of the public health code:

    • Pregnant woman, woman in labour or nursing mother
    • Person deprived of liberty by judicial or administrative decision
    • Person hospitalised without consent and not subject to a legal protection measure, and person admitted to a health or social establishment for purposes other than research
    • Minor
    • Person subject to a period of exclusion for other research
    • Person of full age subject to a legal protection measure (guardianship, curatorship or safeguard of justice), person of full age unable to express their consent and not subject to a protection measure
  9. Person under psychiatric care

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

Coorti e interventi

Gruppo / Coorte
Intervento / Trattamento
Controlli sani
functional tests that reproduce tasks of daily living (timed up and go test with and without dual cognitive task, modified Glittre ADL test)
Pazienti con BPCO
functional tests that reproduce tasks of daily living (timed up and go test with and without dual cognitive task, modified Glittre ADL test)

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Margins of stability
Lasso di tempo: Clinical assessment at baseline
Postural control parameter related to the centre of mass (CoM) and the base of support of the participant, assessed during the functional tests
Clinical assessment at baseline
Margins of stability variability
Lasso di tempo: Clinical assessment at baseline
Coefficient of variation of a postural control parameter related to the centre of mass (CoM) and the base of support of the participant, assessed during the functional tests
Clinical assessment at baseline
Center of Mass velocity
Lasso di tempo: Clinical assessment at baseline
Parameter of participant's Centre of Mass (CoM) during the functional tests
Clinical assessment at baseline
Center of mass displacement
Lasso di tempo: Clinical assessment at baseline
Parameter of participant's Centre of Mass (CoM) during the functional tests
Clinical assessment at baseline

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Evolution of articular angulations
Lasso di tempo: Clinical assessment at baseline
Articular angulations assessed at the ankle, knee, hip, spine and thoracic level during the functional tests
Clinical assessment at baseline
Centre of pressure (CoP) Area
Lasso di tempo: Clinical assessment at baseline
Parameter of participant's Centre of Pressure (CoP) during the sit to stand and stand to sit tasks of the Glittre-ADL test
Clinical assessment at baseline
Centre of pressure (CoP) velocity
Lasso di tempo: Clinical assessment at baseline
Parameter of participant's Centre of Pressure (CoP) during the sit to stand and stand to sit tasks of the Glittre-ADL test
Clinical assessment at baseline
Centre of pressure (CoP) variability
Lasso di tempo: Clinical assessment at baseline
Coefficient of variation of participant's Centre of Pressure (CoP) during the sit to stand and stand to sit tasks of the Glittre-ADL test
Clinical assessment at baseline
Gait Cadence
Lasso di tempo: Clinical assessment at baseline
spatio-temporal parameter of gait assessed during the walking part of the Glittre-ADL test
Clinical assessment at baseline
Gait velocity
Lasso di tempo: Clinical assessment at baseline
spatio-temporal parameter of gait assessed during the walking part of the Glittre-ADL test
Clinical assessment at baseline
Gait phases duration
Lasso di tempo: Clinical assessment at baseline
spatio-temporal parameter of gait assessed during the walking part of the Glittre-ADL test
Clinical assessment at baseline
Step width
Lasso di tempo: Clinical assessment at baseline
spatio-temporal parameter of gait assessed during the walking part of the Glittre-ADL test
Clinical assessment at baseline
Step length
Lasso di tempo: Clinical assessment at baseline
spatio-temporal parameter of gait assessed during the walking part of the Glittre-ADL test
Clinical assessment at baseline
Completion time of the Modified Glittre ADL
Lasso di tempo: Clinical assessment at baseline
Time to complete the modified Glittre-ADL test
Clinical assessment at baseline
Completion time of the timed up and go test
Lasso di tempo: Clinical assessment at baseline
Time to complete the timed up and go test test
Clinical assessment at baseline

Altre misure di risultato

Misura del risultato
Misura Descrizione
Lasso di tempo
Dyspnea assessment scale
Lasso di tempo: Clinical assessment at baseline
assessed by the modified Borg Scale which is a 0 to 10 scale (0 representing no dyspnea, 10 representing the worst imaginable dyspnea). Dyspnea is assessed before, during and after the functional tests
Clinical assessment at baseline
Heart rate
Lasso di tempo: Clinical assessment at baseline
assessed before, during and after functional tests
Clinical assessment at baseline
Leg discomfort scale
Lasso di tempo: Clinical assessment at baseline
assessed on a 0 to 10 scale (0 representing no discomfort, 10 representing the worst imaginable discomfort).Leg discomfort is assessed before, during and after the functional tests
Clinical assessment at baseline
Visual analog scale for pain
Lasso di tempo: Clinical assessment at baseline
Pain is assessed by a visual analog scale which is a 100mm long horizontal line with verbal descriptors at each end to express the extremes of the feeling (Here no pain and the worst imaginable pain)
Clinical assessment at baseline
Pain Drawing scale
Lasso di tempo: Clinical assessment at baseline
participants are invited to identify on a body chart the location of experienced pain.
Clinical assessment at baseline
Multi-dimensional dyspnea profile (MDP)
Lasso di tempo: Clinical assessment at baseline
Dyspnea assessment tool which investigates sensory and affective dimensions of dyspnea
Clinical assessment at baseline
London chest activity of daily living questionnaire (LCADL)
Lasso di tempo: Clinical assessment at baseline
Dyspnea assessment tool which investigates the impact of dyspnea on 15 activities of daily living. A score from 0 to 5 is given for each activity, 5 representing an higher impact of dyspnea on the activity.
Clinical assessment at baseline
Modified Medical Research Council Scale (MMRC)
Lasso di tempo: Clinical assessment at baseline
Dyspnea assessment tool which investigates impact of dyspnea in participants life. This is a 0 to 4 scale with descriptors associated to each number. 4 representing the most severe impact of dyspnea.
Clinical assessment at baseline
Charlson Index
Lasso di tempo: Clinical assessment at baseline
Comorbidities assessment tool which list 19 potential comorbidities associated with a weighted score. The points are attributed when the comorbidity is present. A total score is then calculated. An higher score indicates an higher severity.
Clinical assessment at baseline
Body composition
Lasso di tempo: Clinical assessment at baseline
Determination of fat free mass and fat mass by bioelectrical impedance analysis.
Clinical assessment at baseline
Maximal inspiratory pressure
Lasso di tempo: Clinical assessment at baseline
inspiratory muscles strength assessment
Clinical assessment at baseline
Falls Efficacy Scale - International
Lasso di tempo: Clinical assessment at baseline
Fear of falling assessment tool which investigates fear of falling in 16 different activities. Each activity is scored from 0 to 4 (4 representing an higher fear of falling in this activity). The total score range from 16 to 64 (an higher score indicating a most severe fear of falling)
Clinical assessment at baseline
Number of anterior falls
Lasso di tempo: Clinical assessment at baseline
assessment of fall occurence in the last 12 months
Clinical assessment at baseline
General Practioner assessment of Cognition (GP-COG)
Lasso di tempo: Clinical assessment at baseline
assessment of cognitive function. GP-COG gives a score from 0 to 9 (9 indicating a better cognitive function)
Clinical assessment at baseline
International Physical Activity Questionnaire (IPAQ short-form)
Lasso di tempo: Clinical assessment at baseline
assessment of daily physical activity and sedentarity
Clinical assessment at baseline
COPD assessment test (CAT)
Lasso di tempo: Clinical assessment at baseline
quality of life assessment tool
Clinical assessment at baseline

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Investigatore principale: Graziella Brinchault, MD, University Hospital of Rennes

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Anticipato)

1 febbraio 2022

Completamento primario (Anticipato)

1 settembre 2022

Completamento dello studio (Anticipato)

1 aprile 2023

Date di iscrizione allo studio

Primo inviato

23 novembre 2021

Primo inviato che soddisfa i criteri di controllo qualità

14 gennaio 2022

Primo Inserito (Effettivo)

27 gennaio 2022

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

27 gennaio 2022

Ultimo aggiornamento inviato che soddisfa i criteri QC

14 gennaio 2022

Ultimo verificato

1 gennaio 2022

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

INDECISO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Prove cliniche su quantified analysis of postural control during activities of daily living

Sottoscrivi